secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0000075252-23-000050
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q3 revenue up 3.8% to $2.59B; adjusted EPS $0.44, debt cut $188M
------------------------------------------------------------------------------

- Revenue $2.59B vs $2.497B in Q3 2022, driven by Patient Direct and Medical Distribution growth.
- GAAP net loss per share $(0.08); adjusted net income per share $0.44.
- Total debt paydown of $188M; net debt reduced by $117M.
- Patient Direct outperformed market; Medical Distribution posted mid-single digit growth.
- Operating Model Realignment Program delivered economic benefits; cautious on long-term PPE trajectory.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000007525223000050/0000075252-23-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000007525223000050/omi-20231103.htm
  HTML page:      https://secwatch.observer/filing/0000075252-23-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer